Biochemical and structural impact of two novel missense mutations in cystathionine β-synthase gene associated with homocystinuria.

Autor:	Al-Sadeq DW; College of Medicine, QU Health, Qatar University, Doha, Qatar.; Biomedical Research Center, Qatar University, Doha, Qatar., Conter C; Department of Biotechnology, University of Verona, Verona, Italy.; Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain., Thanassoulas A; College of Medicine, QU Health, Qatar University, Doha, Qatar., Al-Dewik N; Department of Research and Translational and Precision Medicine Research Lab, Women's Wellness and Research Center, Hamad Medical Corporation, and Genomics and Precision Medicine (GPM), College of Health & Life Science (CHLS), Hamad Bin Khalifa University (HBKU), Doha, Qatar., Safieh-Garabedian B; College of Medicine, QU Health, Qatar University, Doha, Qatar., Martínez-Cruz LA; Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain., Nasrallah GK; Biomedical Research Center, Qatar University, Doha, Qatar.; Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar., Astegno A; Department of Biotechnology, University of Verona, Verona, Italy., Nomikos M; College of Medicine, QU Health, Qatar University, Doha, Qatar.
Jazyk:	angličtina
Zdroj:	The Biochemical journal [Biochem J] 2024 Apr 24; Vol. 481 (8), pp. 569-585.
DOI:	10.1042/BCJ20240012
Abstrakt:	Homocystinuria is a rare disease caused by mutations in the CBS gene that results in a deficiency of cystathionine β-synthase (CBS). CBS is an essential pyridoxal 5'-phosphate (PLP)-dependent enzyme in the transsulfuration pathway, responsible for combining serine with homocysteine to produce cystathionine, whose activity is enhanced by the allosteric regulator S-adenosylmethionine (SAM). CBS also plays a role in generating hydrogen sulfide (H2S), a gaseous signaling molecule with diverse regulatory functions within the vascular, nervous, and immune systems. In this study, we present the clinical and biochemical characterization of two novel CBS missense mutations that do not respond to pyridoxine treatment, namely c.689T > A (L230Q) and 215A > T (K72I), identified in a Chinese patient. We observed that the disease-associated K72I genetic variant had no apparent effects on the spectroscopic and catalytic properties of the full-length enzyme. In contrast, the L230Q variant expressed in Escherichia coli did not fully retain heme and when compared with the wild-type enzyme, it exhibited more significant impairments in both the canonical cystathionine-synthesis and the alternative H2S-producing reactions. This reduced activity is consistent with both in vitro and in silico evidence, which indicates that the L230Q mutation significantly decreases the overall protein's stability, which in turn, may represent the underlying cause of its pathogenicity. (© 2024 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu